Learn about cystic fibrosis ... our understanding of cystic fibrosis every day, helping to shape clinical care practices for people living with the disease for years to come. These include studies ...

John Stewart, National Director for Specialised Commissioning, said: “Since 2019, thousands of people with cystic fibrosis have been able to benefit ... In the event of non-submission of data to the ...

The global Enteral Formula industry has an estimated market valuation of USD 8.0 billion by 2024 and is projected to grow at ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and ...

Virtual choir program founder Ashley Ballou-Bonnema shares her selfless story on living with and advocating for a life with the chronic disease.

Objective: Conventional fine-needle aspiration biopsy (FNAB) for cystic thyroid nodules (CTNs) has a high rate of nondiagnostic and false-negative results. Ultrasound-guided FNAB (UG-FNAB ...

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025 Heart Disease and Stroke Statistics: ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

Holding the lifeblood of medical research ransom — without warning, without consultation — is shortsighted at best and ...